Product image of Medikarb (Carbon Dioxide) supplied by GNH India

Medikarb

Active Ingredient:
Carbon Dioxide
Origin:
EU

Medikarb (Carbon Dioxide)

Carbon Dioxide, the active ingredient in Medikarb, is a medical gas presented as a gas for inhalation, intrapericardial and intraperitoneal use. It is employed in clinical settings to influence respiratory drive and maintain acid‑base balance during various procedures.\n\nGNH India supplies Medikarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Manufacturer / TM Owner

S.E. Carburos Metálicos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Medikarb provides carbon dioxide for physiological modulation and surgical applications.\n\n- Laparoscopic surgery: facilitates abdominal insufflation to create a working space for minimally invasive procedures.\n- Intrapericardial administration: assists in cardiac function assessment and pericardial space management.\n- Inhalational testing: stimulates respiratory drive during diagnostic respiratory function tests.

How It Works

  • Carbon dioxide delivered as a medical gas diffuses into blood, raising arterial PaCO₂. The increase stimulates central chemoreceptors in the medulla, enhancing respiratory drive, and contributes to acid‑base regulation by shifting the bicarbonate buffer system. In surgical settings, CO₂ insufflation creates a pneumoperitoneum or pneumopericardium, providing space for operative visualization while exerting minimal inflammatory response.

Side Effects

  • Carbon dioxide administration can be associated with a range of adverse reactions.\n\nCommon Side Effects:\n- Abdominal discomfort or shoulder pain due to diaphragmatic irritation.\n- Transient hypercapnia leading to mild headache.\n- Nausea or vomiting during insufflation.\n- Temporary hypotension from vasodilation.\n- Mild respiratory irritation causing cough.\n\nSerious or Rare Side Effects:\n- Gas embolism with potential cardiovascular collapse.\n- Severe hypercapnia causing respiratory acidosis.\n- Significant hemodynamic instability requiring intervention.\n- Infection risk if sterility is compromised.

Precautions & Warnings

  • When using Medikarb, careful patient assessment and monitoring are essential.\n\n- Patient selection: evaluate baseline respiratory function and cardiovascular status before administration.\n- Monitoring: continuous capnography and hemodynamic monitoring during and after gas delivery.\n- Contraindications: avoid in patients with severe chronic obstructive pulmonary disease or uncontrolled hypertension.\n- Drug interactions: be cautious when combined with potent ventilatory depressants such as opioids or sedatives.\n- Storage: Store at ambient temperature: keep cylinders upright, protect from heat and direct sunlight.

Avoid Interactions

  • Carbon dioxide can interact with other agents that affect ventilation or gas composition.\n\nMajor Interactions (Avoid):\n- High‑concentration oxygen therapy: may blunt CO₂‑driven respiratory stimulation.\n- Concurrent use of potent ventilatory depressants (e.g., opioids, barbiturates): risk of severe hypercapnia.\n- Nitrous oxide administration: increased risk of gas embolism.\n\nModerate Interactions (Monitor Closely):\n- Sedative agents (benzodiazepines, propofol): may require closer capnographic monitoring.\n- Beta‑blockers: can mask tachycardic response to hypercapnia.\n- ACE inhibitors: potential for additive hypotensive effects.

Frequently Asked Questions

Medikarb is a medical‑grade carbon dioxide gas used to modulate respiratory drive, assist in diagnostic respiratory tests, and provide insufflation during laparoscopic, intrapericardial, or intraperitoneal procedures. Its primary role is to create a controlled environment for surgical visualization or to stimulate breathing in specific clinical assessments.

When administered, carbon dioxide diffuses into the bloodstream, raising arterial PaCO₂ levels. This elevation activates central chemoreceptors in the brainstem, which increase the respiratory rate and depth. In surgical contexts, CO₂ creates a pneumoperitoneum or pneumopericardium, expanding the cavity to improve operative access while maintaining physiological stability.

The specific dose and delivery parameters for Medikarb are determined by the prescribing clinician based on the intended procedure, patient characteristics, and monitoring results. Healthcare professionals set the flow rate, concentration, and duration to achieve the desired physiological effect while ensuring safety.

The safety of carbon dioxide medical gas in pregnancy or lactation has not been definitively established. Use should be limited to situations where the potential benefit outweighs any possible risk, and it should be administered under strict medical supervision with appropriate fetal monitoring when applicable.

To place an order, submit an enquiry on the Medikarb product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with other medical gases such as oxygen or nitrous oxide, carbon dioxide uniquely stimulates respiratory drive by raising PaCO₂ and is primarily used for insufflation rather than oxygenation. Its physiological effects differ, making it suitable for specific surgical and diagnostic applications where controlled hypercapnia is desired.

Medikarb cylinders should be stored at ambient temperature, kept upright, and protected from heat sources and direct sunlight. Ensure cylinders are secured to prevent tipping, and handle them with appropriate protective equipment to avoid accidental release or injury.

Administration routes include inhalation through a calibrated delivery system, intrapericardial injection for cardiac procedures, or intraperitoneal insufflation during laparoscopic surgery. The gas is delivered via specialized equipment that controls flow rate and pressure, and administration is performed by trained healthcare professionals under continuous monitoring.

The most serious risks include gas embolism, severe hypercapnia leading to respiratory acidosis, and significant hemodynamic instability such as hypotension or cardiovascular collapse. Prompt recognition and immediate intervention are critical to mitigate these potentially life‑threatening complications.

Medikarb should be avoided in patients with uncontrolled severe chronic obstructive pulmonary disease, uncontrolled hypertension, or known hypersensitivity to carbon dioxide. It is also contraindicated in individuals where the creation of a pneumoperitoneum or pneumopericardium is medically inappropriate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carbon Dioxide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT